Evidence map›Paper›PMID 24169366›Full record

ArticleEpigenetics2014

In situ histone landscape of nephrogenesis.

Nathan McLaughlin, Fenglin Wang, Zubaida Saifudeen, Samir S El-Dahr

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 38 citations in OpenAlex.

  1. Epigenetic regulation of kidney development.Nature reviews. Nephrology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Absent, Small, or Homeotic 2-Like-Mediated H3K4 Methylation and Nephrogenesis.Journal of the American Society of Nephrology : JASN · 2025
    Article
  6. Article
  7. Review
  8. Sex-specific epigenetic programming in renal fibrosis and inflammation.American journal of physiology. Renal physiology · 2023
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Epigenetic regulation of renal development.Seminars in cell & developmental biology · 2019
    Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Epigenetics of Renal Development and Disease.The Yale journal of biology and medicine · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Nathan McLaughlinDepartment of Pediatrics; Tulane University School of Medicine; New Orleans, LA USA; Biomedical Sciences Program; Tulane University School of Medicine; New Orleans, LA USA.
Fenglin WangDepartment of Pediatrics; Tulane University School of Medicine; New Orleans, LA USA; Biomedical Sciences Program; Tulane University School of Medicine; New Orleans, LA USA.
Zubaida SaifudeenDepartment of Pediatrics; Tulane University School of Medicine; New Orleans, LA USA; The Renal and Hypertension Center of Excellence; Tulane University School of Medicine; New Orleans, LA USA.
Samir S El-DahrDepartment of Pediatrics; Tulane University School of Medicine; New Orleans, LA USA; The Renal and Hypertension Center of Excellence; Tulane University School of Medicine; New Orleans, LA USA.
Tulane University · USUniversity of New Orleans · US

Funding

Single-Cell Epigenomics, Transcriptomics, and Bioinformatics CoreP50DK096373 · NIDDK · UNIVERSITY OF VIRGINIA · PI PATRICIO E. RAY · 2012 to 2026
$13.8M
Translational Research in Hypertension and Renal BiologyP30GM103337 · NIGMS · TULANE UNIVERSITY OF LOUISIANA · PI NAVAR, LUIS GABRIEL · 2012 to 2016
$5.8M
Inducible Dysplastic Nephropathy in B2-Deficient MiceR01DK056264 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI EL-DAHR, SAMIR S · 2000 to 2014
$3.8M
Histone Deacetylases and Kidney DevelopmentR01DK079886 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI EL-DAHR, SAMIR S · 2009 to 2010
$670k
NIDDK NIH HHS 1P50 DK096373NIDDK NIH HHS P50 DK096373NIDDK NIH HHS R01 DK056264NIDDK NIH HHS R01 DK079886NIDDK NIH HHS R01-DK079886NIDDK NIH HHS R01-DK56264NIGMS NIH HHS P30 GM103337
6 · The paper itself

Abstract

In the developing kidney, self-renewing progenitors respond to inductive signaling from the adjacent branching ureteric bud by undergoing mesenchyme-to-epithelium transition. Nascent nephrons subsequently undergo elongation, segmentation, and differentiation into a mature renal epithelium with diverse functions. Epigenetic mechanisms have been implicated in impacting cell fate decisions during nephrogenesis; however, the chromatin landscape of nephron progenitors and daughter differentiating cells are largely unknown. Here, we examined the spatiotemporal expression patterns of histone H3 methylation and histone methyltransferases in E15.5 mouse kidneys. Kidney sections were probed with antibodies against histone modifications, enzymes, and markers of progenitors and differentiation. The results revealed that: (1) nephron progenitor cells exhibit a broad histone methylation signature that comprises both "active" and "repressive" marks (H3K4me3/K9me3/K27me3/R2me2/R17me2); (2) nascent nephrons retain high H3K4me3 but show downregulation of H3K9/K27me3 and; (3) maturing epithelial tubules acquire high levels of H3K79me2/3. Consistent with respective histone marks, the H3K4 methyltransferase, Ash2l, is expressed in progenitors and nascent nephrons, whereas the H3K9/K27 methyltransferases, G9a/Ezh2, are more enriched in progenitors than nascent nephrons. We conclude that combinatorial histone signatures correlate with cell fate decisions during nephrogenesis.

Indexed as

AnimalsArginineCell DifferentiationChromatinHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesKidneyLysineMethylationMiceNephronsOrganogenesisStem CellsArginineChromatinHistone-Lysine N-MethyltransferaseHistone MethyltransferasesHistonesLysinechromatin landscapedifferentiationhistone methylationhistone modificationskidney developmentnephrogenesisnephron progenitors

Identifiers

PMID24169366
PMCPMC3962532
OpenAlexW1984756569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.